🇺🇸 FDA
Pipeline program

Only conventional drug therapy

NCRC2024001

Unknown small_molecule active

Quick answer

Only conventional drug therapy for Pulmonary Artery Hypertension is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Pulmonary Artery Hypertension
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials